Manufacturer:
Novartis
Route of Administration:
Intravenous
Site of Care:
Outpatient
Website:
Enrollment Forms:
Synergen Prescription Form
Approved Indication:
- treatment and prevention of postmenopausal osteoporosis
- treatment to increase bone mass in men with osteoporosis
- treatment and prevention of glucocorticoid-induced osteoporosis
- treatment of Paget’s disease of bone in men and women
Conditions:
- Osteoporosis
- Paget’s Disease
Therapeutic Area:
- Endocrinology
- Geriatrics